Tamarack Advisers’s Gilead Sciences GILD Stock Holding History

Tamarack Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,500	Closed	-$340K	–	24
2018 Q3	$340K	Buy	+2,500	New	+$189K	0.1%	27

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tamarack Advisers's GILD Position: Q2 2022 in Review

Tamarack Advisers sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 75,000 shares — an estimated $4.46M sold.

Tamarack Advisers first reported a position in GILD in Q4 2016 and held it in 9 quarters. The position peaked at $14.2M in Q2 2018. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

Tamarack Advisers reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
Tamarack Advisers sold 75,000 Gilead Sciences shares in Q2 2022, an estimated $4.46M.
Tamarack Advisers first reported a position in Gilead Sciences in Q4 2016 and held it in 9 quarters.
Tamarack Advisers's Gilead Sciences position peaked at $14.2M in Q2 2018.
1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Tamarack Advisers's 13F filing for Q2 2022, filed 16 Aug 2022.